Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older
- People whose general health and ability to carry out daily activities meets a certain level, as measured by a standard cancer research scale (confirm with trial site)
- People who have been diagnosed with advanced non-small cell lung cancer (stage IIIB, IIIC, or stage IV), confirmed through laboratory testing of tissue samples
- For the retrospective (past records) group: people who have already received at least one course of immunotherapy treatment (a maintenance therapy called Durvalumab is also permitted)
- For the prospective (new participants) group: people for whom a doctor has determined that immunotherapy is the appropriate first treatment for their cancer
- People who have cancer that has spread to the brain are permitted to join
- For the retrospective group: people whose cancer involves specific genetic changes that may drive cancer growth are also permitted
- For the prospective group: people who have signed and dated a consent form showing they have been informed about and understand all important aspects of the study before joining
- For the prospective group: people for whom at least one preserved tissue sample is available for laboratory analysis
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- For the retrospective group: people for whom there is not enough basic treatment history information available
- For the prospective group: people who have already received treatment for advanced-stage disease
- People who are unavailable or unable to follow the required study procedures, including completing quality-of-life questionnaires
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 022390 3647
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Response Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.